Journal
CARCINOGENESIS
Volume 26, Issue 4, Pages 703-711Publisher
OXFORD UNIV PRESS
DOI: 10.1093/carcin/bgh293
Keywords
-
Categories
Funding
- NCI NIH HHS [F32 CA101560-02, UO1 CA84243, F32 CA101560, F32 CA101560-03] Funding Source: Medline
Ask authors/readers for more resources
This review presents a brief synopsis of recent progress in the area of cancer stem cells, with emphasis on leukemia and breast cancer, and discusses potential limitations to accomplishing the ultimate goal of eradicating residual disease in cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
